SOURCE: Horizon Pharma plc

Horizon Pharma plc

February 24, 2015 07:30 ET

Horizon Pharma plc to Present at the Cowen and Company 35th Annual Health Care Conference

DUBLIN, IRELAND--(Marketwired - Feb 24, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the Cowen and Company 35th Annual Health Care Conference on Monday, March 2, 2015 at 2:10 p.m. Eastern Time in Boston, MA. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.

About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The Company markets a portfolio of products in arthritis, inflammation and orphan diseases. Horizon's U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS® (ibuprofen/famotidine), PENNSAID® (diclofenac sodium topical solution) 2% w/w, RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole magnesium). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.

Contact Information

  • Contacts:

    Investors:
    Robert F. Carey
    Executive Vice President, Chief Business Officer
    Email Contact

    Media:
    Geoff Curtis
    DJE Science
    Email Contact